HER2-Positive Breast Cancer: New Findings, Expanded Options, and an Evolving Treatment Paradigm

Watch this on-demand Webcast capturing expert presentations focused on the latest treatment strategies for patients with HER2+ breast cancer in the early and metastatic settings.

Neelima Denduluri, MD, FASCO Lee Schwartzberg, MD, FACP Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: August 11, 2020 Expired: No longer available for credit

Introduction to HER2-Positive Breast Cancer: New Findings, Expanded Options, and an Evolving Treatment Paradigm (1 min)

Expert Guidance on the Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer (42 mins)

HER2-Positive Metastatic Breast Cancer: Current Status and Promising Agents on the Horizon (32 mins)

Download this short slideset of essential highlights from a live presentation on the latest developments in managing HER2-positive breast cancer.

Neelima Denduluri, MD, FASCO Lee Schwartzberg, MD, FACP Released: July 8, 2020

Review the latest clinical data and expert guidance on management of HER2-positive early-stage breast cancer, including how to assess risk and plan (neo)adjuvant therapy; treat lower- vs higher-risk disease; and optimally manage adverse events associated with HER2-targeted therapy.

Lee Schwartzberg, MD, FACP Released: June 30, 2020

Get up to date on current and emerging HER2-targeted TKIs and antibody–drug conjugates for HER2-positive metastatic breast cancer across multiple lines of therapy.

Neelima Denduluri, MD, FASCO Released: June 30, 2020